Impact of Seborrheic Dermatitis Manifestations on Quality of Life During COVID-19 Pandemic

Abstract

Seborrheic dermatitis is a globally prevalent condition affecting individuals of all ages, influenced by both genetic factors and environmental exposures. These factors can trigger the onset or exacerbation of the condition in those with pre-existing epidermal barrier dysfunction. It presents as a more aggressive form of dandruff, manifesting with pronounced symptoms including red patches or scales on the scalp, and a combination of dry and oily skin. Although not contagious, seborrheic dermatitis can lead to discomfort due to itching, unsightly clothing marks, and even social unease. This dermatological issue, sometimes referred to as seborrheic eczema, can pose diagnostic challenges due to its resemblance to other allergic reactions or skin conditions like psoriasis. The seborrheic dermatitis market can be segmented based on treatment, diagnosis, dosage form, route of administration, end users, and distribution channels. Understanding the growth within these segments is essential for identifying areas with lower growth potential and providing market stakeholders with valuable insights to make strategic decisions. This study aims to assess the real impact of the COVID-19 pandemic on the quality of life of seborrheic dermatitis patients in Romania. The findings suggest that the emergence of the COVID-19 virus significantly disrupted public health, exacerbating various skin and systemic conditions, including those affecting the central nervous system (CNS). Over the course of two years, individuals with seborrheic dermatitis have had to adapt to new social norms, such as wearing protective masks and utilizing necessary detergents and disinfectants, which could potentially aggravate their condition.